ArticleAnnals of medicine2025

L3-SMI as a predictor of overall survival in oesophageal cancer patients receiving PD-1 inhibitors combined with chemotherapy.

Huiya Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.